CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Shrishrimal Sumi SVP Chief Risk Officer | Grant or award | +2,889 | $0.00 | $3 | 15,146 |
| 2022-03-08 | Selvaraj Shelly Ramasamy SVP Chief Information Officer | Grant or award | +2,889 | $0.00 | $3 | 15,685 |
| 2022-03-08 | SAYER KEVIN R Chairman, CEO & President | Grant or award | +16,251 | $0.00 | $16 | 110,868 |
| 2022-03-08 | Regan Barry J. EVP Global Operations | Grant or award | +4,984 | $0.00 | $5 | 18,112 |
| 2022-03-08 | Patterson Chad EVP, Global Marketing | Grant or award | +5,297 | $0.00 | $5 | 17,825 |
| 2022-03-08 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Grant or award | +4,984 | $0.00 | $5 | 39,354 |
| 2022-03-08 | Leach Jacob Steven EVP Chief Technology Officer | Grant or award | +6,741 | $0.00 | $7 | 79,019 |
| 2022-03-08 | Flynn Paul R EVP Global Revenue | Grant or award | +5,297 | $0.00 | $5 | 19,150 |
| 2022-03-08 | Dolan Matthew Vincent SVP Corporate Development | Grant or award | +2,889 | $0.00 | $3 | 10,435 |
| 2022-03-08 | Brown Michael Jon EVP Chief Legal Officer | Grant or award | +12,038 | $0.00 | $12 | 12,038 |
| 2022-03-08 | Balo Andrew K EVP, Global Medical Affairs | Grant or award | +4,984 | $0.00 | $5 | 19,045 |
| 2022-03-08 | Abbey Donald EVP Quality Regulatory Affairs | Grant or award | +4,984 | $0.00 | $5 | 53,658 |
| 2022-03-04 | Sylvain Jereme M EVP, Chief Financial Officer | Sale | −600 | $422.94 | $254K | 14,662 |
| 2022-03-01 | Patterson Chad EVP, Global Marketing | Sale | −46 | $413.97 | $19K | 12,528 |
| 2022-02-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −250 | $394.33 | $99K | 34,370 |
| 2022-02-14 | SAYER KEVIN R Chairman, CEO & President | Sale | −3,000 | $418.04 | $1.3M | 94,617 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −100 | $428.55 | $43K | 7,566 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −100 | $430.06 | $43K | 7,466 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −100 | $435.64 | $44K | 7,366 |
| 2022-02-10 | KAHN BARBARA Director | Sale | −100 | $438.21 | $44K | 7,266 |
Page 26 of 40 · 785 trades